Tvardi Therapeutics, Inc. short interest in 2026
In 2026, Tvardi Therapeutics, Inc.'s disclosed short interest ran from 5.84% of shares outstanding on 15 Jan 2026 to 1.92% on 15 Sep 2026, a change of -3.92 percentage points. The year's high was 7.87% on 13 Feb 2026 and its low 1.30% on 14 Aug 2026, averaging 5.08% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.05 days on 13 Mar 2026. Full history: Tvardi Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 5.84% (15 Jan 2026)
- End of year
- 1.92% (15 Sep 2026)
- Change
- -3.92 pp
- High
- 7.87% (13 Feb 2026)
- Low
- 1.30% (14 Aug 2026)
- Average
- 5.08%
- Highest days to cover
- 16.05 (13 Mar 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 5.84% | 4.42 | |
| 30 Jan 2026 | 7.08% | 13.20 | |
| 13 Feb 2026 | 7.87% | 11.89 | |
| 27 Feb 2026 | 6.79% | 15.22 | |
| 13 Mar 2026 | 7.13% | 16.05 | |
| 31 Mar 2026 | 6.97% | 13.37 | 10-K filed, results (8-K) |
| 15 Apr 2026 | 5.91% | 8.07 | |
| 30 Apr 2026 | 5.43% | 14.85 | |
| 15 May 2026 | 5.22% | 11.09 | 10-Q filed, results (8-K) |
| 29 May 2026 | 4.65% | 7.99 | |
| 15 Jun 2026 | 4.24% | 6.88 | |
| 30 Jun 2026 | 5.41% | 1.00 | |
| 15 Jul 2026 | 5.79% | 1.00 | |
| 31 Jul 2026 | 2.80% | 1.00 | |
| 14 Aug 2026 | 1.30% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 1.99% | 1.87 | |
| 15 Sep 2026 | 1.92% | 2.29 |
See also: Tvardi Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.